{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:08:51Z","timestamp":1778522931451,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\\u201301370"],"award-info":[{"award-number":["PI22\\u201301370"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.cmi.2025.06.007","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:53:54Z","timestamp":1749657234000},"page":"1855-1864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Humoral and cellular immune responses in people living with HIV following successive COVID-19 vaccine booster doses"],"prefix":"10.1016","volume":"31","author":[{"given":"Jos\u00e9 L.","family":"Casado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Vizcarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adri\u00e1n","family":"Mart\u00edn-Hondarza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"P\u00e9rez-El\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Fern\u00e1ndez-Chica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Mart\u00edn-Colmenarejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.06.007_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.917905","article-title":"Comparison of IgA, IgG, and neutralizing antibody responses following immunization with moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm's COVID-19 vaccines","volume":"13","author":"Adjobimey","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2025.06.007_bib2","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.vaccine.2022.03.069","article-title":"Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies","volume":"40","author":"Sughayer","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2025.06.007_bib3","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cid\/ciab687","article-title":"Effectiveness of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccines for preventing coronavirus disease 2019 hospitalizations in the United States","volume":"74","author":"Tenforde","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.06.007_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cmi.2021.09.036","article-title":"Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review","volume":"28","author":"Galmiche","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.06.007_bib5","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/QAD.0000000000003166","article-title":"Impaired antibody response to COVID-19 vaccination in advanced HIV infection","volume":"36","author":"Hassold","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2025.06.007_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105577","article-title":"Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: Heterogeneity in the immune response and crucial role of Omicron-adapted booster doses","volume":"113","author":"Ciabattini","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cmi.2025.06.007_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/QAD.0000000000003469","article-title":"Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy","volume":"37","author":"Lapointe","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2025.06.007_bib8","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/QAD.0000000000003504","article-title":"Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people living with HIV","volume":"37","author":"Casado","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2025.06.007_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28602","article-title":"Reduced neutralizing antibody response to SARS-CoV-2 vaccine booster dose in people living with HIV with severe immunosuppression","volume":"95","author":"Corma-G\u00f3mez","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.cmi.2025.06.007_bib10","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/vaccines12101172","article-title":"Immunogenicity and determinants of antibody response to the BNT162b2 mRNA vaccine: A longitudinal study in a cohort of people living with HIV","volume":"12","author":"Baldovin","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.cmi.2025.06.007_bib11","article-title":"Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines","volume":"9","author":"Hvidt","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.cmi.2025.06.007_bib12","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2352-3018(21)00103-X","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: A single-arm substudy of a phase 2\/3 clinical trial","volume":"8","author":"Frater","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.cmi.2025.06.007_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22552-y","article-title":"Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations","volume":"12","author":"Jacobsen","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2025.06.007_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jinf.2023.04.012","article-title":"Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: Eight-month analyses of the COV-BOOST trial","volume":"87","author":"Liu","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2025.06.007_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1129753","article-title":"Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered","volume":"14","author":"L\u00f3pez-Cort\u00e9s","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2025.06.007_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2387906","article-title":"Heterologous mRNA\/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2:COVARNA Consortium","volume":"13","author":"Marcos-Villar","year":"2024","journal-title":"Emerg Microbe. Infect"},{"key":"10.1016\/j.cmi.2025.06.007_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1002748","article-title":"Impact of SARS-CoV-2-specific memory B cells on the immune response after mRNA-based Comirnaty vaccine in seronegative health care workers","volume":"13","author":"Vallejo","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2025.06.007_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jmii.2024.02.004","article-title":"Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV","volume":"57","author":"Liu","year":"2024","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.cmi.2025.06.007_bib19","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/vaccines11111647","article-title":"Role of immunoglobulin A in COVID-19 and influenza infections","volume":"11","author":"Tyagi","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.cmi.2025.06.007_bib20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/eji.202149655","article-title":"The presence of serum anti-SARS-CoV-2 IgA appears to protect primary health care workers from COVID-19","volume":"52","author":"Hennings","year":"2022","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cmi.2025.06.007_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1136308","article-title":"Detection of specific RBD+ IgG+ memory B cells by flow cytometry in healthcare workers and patients with inborn errors of immunity after BNT162b2 m RNA COVID-19 vaccination","volume":"14","author":"Del Pino-Molina","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2025.06.007_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105862","article-title":"Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles","volume":"26","author":"Touizer","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.cmi.2025.06.007_bib23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/infdis\/jiae249","article-title":"Informing the need for a SARS-CoV-2 booster based on the immune responses among young healthy adults to variants circulating in late 2023","volume":"230","author":"Nguyen","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2025.06.007_bib24","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1097\/CM9.0000000000003176","article-title":"SARS-CoV-2-specific T-cell responses are induced in people living with human immunodeficiency virus after booster vaccination","volume":"137","author":"Wang","year":"2024","journal-title":"Chin Med J"},{"key":"10.1016\/j.cmi.2025.06.007_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/v16050661","article-title":"T-cell responses to COVID-19 vaccines and breakthrough infection in people living with HIV receiving antiretroviral therapy","volume":"16","author":"Datwani","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.cmi.2025.06.007_bib26","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1016\/j.vaccine.2024.04.026","article-title":"Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient","volume":"42","author":"Sukik","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2025.06.007_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107110","article-title":"Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study-ANRS0001s COV-POPART","volume":"146","author":"Loubet","year":"2024","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2025.06.007_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijid.2023.06.010","article-title":"Neutralizing activity and T-cell response after bivalent fifth dose of messenger RNA vaccine in people living with HIV","volume":"134","author":"Vergori","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2025.06.007_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3390\/idr14040057","article-title":"Mix-and-match COVID-19 vaccinations (heterologous boost): A review","volume":"14","author":"Garg","year":"2022","journal-title":"Infect Dis Rep"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25002940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25002940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:11:13Z","timestamp":1778519473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25002940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1198743X25002940"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.06.007","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humoral and cellular immune responses in people living with HIV following successive COVID-19 vaccine booster doses","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}